首页 > 最新文献

BJS Open最新文献

英文 中文
Predicting postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: retrospective cohort study. 预测细胞减少手术和腹腔热化疗后的术后并发症:回顾性队列研究。
IF 4.5 3区 医学 Q1 SURGERY Pub Date : 2025-07-01 DOI: 10.1093/bjsopen/zraf064
Lorena Martin-Roman, Shigeki Kusamura, Marcello Guaglio, Gaia Colletti, Tommaso Cavalleri, Marcello Deraco, Dario Baratti

Background: Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is an effective but potentially highly morbid treatment option for peritoneal surface malignancies. Adequate risk assessment is fundamental for clinical decision-making and informed patient consent. The aim of this study was to construct a validated nomogram predicting the risk of severe postoperative complications based exclusively on preoperative variables.

Methods: A prospective database of patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single institution between February 1995 and April 2023 was reviewed. The cohort was divided randomly into derivation and validation cohorts (70 : 30). The primary outcome measure was postoperative complications (National Cancer Institute Common Terminology Criteria for Adverse Events grade ≥ 3). Binary logistic regression identified preoperative variables significantly associated with postoperative morbidity. A nomogram was constructed based on the results of the multivariable analysis. The model's performance was evaluated on the validation cohort by receiver operating characteristic curve analysis.

Results: A total of 1039 patients were analysed. The majority of the patients were female (58.8%) and the median age was 56 (interquartile range 46-64) years. The postoperative complication rate was 37.7%, and the reoperation rate 12.7%. A nomogram was constructed based on the following predictive factors: age, body mass index, high-grade histology, disease identified in the left upper quadrant and surrounding the stomach and small bowel mesentery on preoperative imaging, preoperative white blood cell count, and Onodera nutritional index score. Receiver operating characteristic curve analysis showed an area under the curve of 0.707 with accurate calibration curves.

Conclusion: Preoperative variables were selected and included in a simple nomogram predicting the risk of postoperative complications. This nomogram could aid clinicians in decision-making and patients in making informed decisions.

背景:细胞减少手术和腹腔内高温化疗是腹膜表面恶性肿瘤的一种有效但潜在高度病态的治疗选择。充分的风险评估是临床决策和患者知情同意的基础。本研究的目的是建立一个有效的nomogram预测严重的术后并发症的风险仅基于术前变量。方法:回顾1995年2月至2023年4月在同一医院接受细胞减少手术和腹腔热化疗的患者的前瞻性数据库。该队列随机分为推导组和验证组(70:30)。主要结局指标为术后并发症(美国国家癌症研究所不良事件通用术语标准≥3级)。二元逻辑回归发现术前变量与术后发病率显著相关。根据多变量分析的结果,构造了一个模态图。通过受试者工作特征曲线分析,在验证队列上评价模型的性能。结果:共分析1039例患者。患者以女性居多(58.8%),中位年龄56岁(四分位数间距46 ~ 64岁)。术后并发症发生率为37.7%,再手术率为12.7%。基于以下预测因素:年龄、体重指数、高级别组织学、术前影像学检查发现的左上象限及胃、小肠肠系膜周围病变、术前白细胞计数、Onodera营养指数评分,构建nomogram。接收机工作特性曲线分析显示,曲线下面积为0.707,校准曲线准确。结论:选择术前变量并将其纳入预测术后并发症风险的简单nomogram。该图可以帮助临床医生在决策和患者作出明智的决定。
{"title":"Predicting postoperative complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: retrospective cohort study.","authors":"Lorena Martin-Roman, Shigeki Kusamura, Marcello Guaglio, Gaia Colletti, Tommaso Cavalleri, Marcello Deraco, Dario Baratti","doi":"10.1093/bjsopen/zraf064","DOIUrl":"10.1093/bjsopen/zraf064","url":null,"abstract":"<p><strong>Background: </strong>Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy is an effective but potentially highly morbid treatment option for peritoneal surface malignancies. Adequate risk assessment is fundamental for clinical decision-making and informed patient consent. The aim of this study was to construct a validated nomogram predicting the risk of severe postoperative complications based exclusively on preoperative variables.</p><p><strong>Methods: </strong>A prospective database of patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in a single institution between February 1995 and April 2023 was reviewed. The cohort was divided randomly into derivation and validation cohorts (70 : 30). The primary outcome measure was postoperative complications (National Cancer Institute Common Terminology Criteria for Adverse Events grade ≥ 3). Binary logistic regression identified preoperative variables significantly associated with postoperative morbidity. A nomogram was constructed based on the results of the multivariable analysis. The model's performance was evaluated on the validation cohort by receiver operating characteristic curve analysis.</p><p><strong>Results: </strong>A total of 1039 patients were analysed. The majority of the patients were female (58.8%) and the median age was 56 (interquartile range 46-64) years. The postoperative complication rate was 37.7%, and the reoperation rate 12.7%. A nomogram was constructed based on the following predictive factors: age, body mass index, high-grade histology, disease identified in the left upper quadrant and surrounding the stomach and small bowel mesentery on preoperative imaging, preoperative white blood cell count, and Onodera nutritional index score. Receiver operating characteristic curve analysis showed an area under the curve of 0.707 with accurate calibration curves.</p><p><strong>Conclusion: </strong>Preoperative variables were selected and included in a simple nomogram predicting the risk of postoperative complications. This nomogram could aid clinicians in decision-making and patients in making informed decisions.</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"9 4","pages":""},"PeriodicalIF":4.5,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12342451/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144833918","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post-thyroid surgery adhesion prevention using oxidized regenerated cellulose and hyaluronic acid: prospective, single-blinded, randomized study. 氧化再生纤维素和透明质酸预防甲状腺术后粘连:前瞻性、单盲、随机研究。
IF 4.5 3区 医学 Q1 SURGERY Pub Date : 2025-07-01 DOI: 10.1093/bjsopen/zraf079
Ting-Chun Kuo, Kuen-Yuan Chen, Yi-Jhih Tsai, Ming-Tsan Lin, Chin-Hao Chang, Ming-Hsun Wu

Background: Postoperative adhesions following thyroidectomy significantly affect patient quality of life, yet prevention strategies remain understudied. This trial evaluated the safety and efficacy of oxidized regenerated cellulose and high molecular weight hyaluronic acid in preventing post-thyroidectomy adhesions.

Methods: In this prospective, single-blinded, randomized study, patients undergoing thyroidectomy were randomized 1 : 1 : 1 to receive oxidized regenerated cellulose (Interceed™), high molecular weight hyaluronic acid (HANBIO BarriGel), or no adhesion barrier (control). The primary outcome was change in the Dysphagia Handicap Index (DHI) from baseline to 1 month. Secondary outcomes included the Voice Handicap Index, Swallowing Impairment Score, laryngotracheal elevation, and adhesion severity scores at 2 weeks, and 1, 6, and 12 months after operation.

Results: Forty -five patients were enrolled. Changes in DHI were not significant from baseline to 1 month among the three groups. The adhesion barrier groups demonstrated significantly smaller increases in Voice Handicap Index scores compared with the control group at 2 weeks (oxidized regenerated cellulose: mean(s.d.) 4.8(5.8); high molecular weight hyaluronic acid: 0.8(6.3); control: 8.4(9.6); P = 0.032) and at 1 month (3.0(5.2), 1.0(7.1), and 9.1(12.3), respectively; P = 0.047). Changes in Swallowing Impairment Scores were significantly lower in the adhesion barrier groups (2.1(5.6) versus 6.0(5.9); P = 0.037), although no significant differences were observed among the three groups (oxidized regenerated cellulose: 1.4(4.2); high molecular weight hyaluronic acid: 2.8(6.8); control: 6.0(5.9); P = 0.095) at 2 weeks. The high molecular weight hyaluronic acid group demonstrated superior preservation of laryngotracheal elevation among groups (P = 0.006) and compared with the oxidized regenerated cellulose group (P = 0.041) at 1 month. No adhesion barrier-related complications were observed. By 6 months, most parameters had returned to near-baseline levels across all groups.

Conclusion: Both oxidized regenerated cellulose and high molecular weight hyaluronic acid appear safe and potentially effective in reducing early post-thyroidectomy adhesion symptoms, with high molecular weight hyaluronic acid showing superior outcomes in certain parameters. These findings support the use of adhesion barriers in thyroid surgery, although larger studies are needed to confirm their long-term benefits.

Registration number: NCT05851560 (http://www.clinicaltrials.gov).

背景:甲状腺切除术后粘连显著影响患者的生活质量,但预防策略仍有待研究。本试验评估氧化再生纤维素和高分子量透明质酸预防甲状腺切除术后粘连的安全性和有效性。方法:在这项前瞻性、单盲、随机研究中,接受甲状腺切除术的患者以1:1的比例随机接受氧化再生纤维素(Interceed™)、高分子量透明质酸(HANBIO BarriGel)或无粘附屏障(对照组)治疗。主要终点是吞咽困难障碍指数(DHI)从基线到1个月的变化。次要结果包括术后2周、1、6、12个月的语音障碍指数、吞咽障碍评分、喉气管抬高和粘连严重程度评分。结果:45例患者入组。三组患者从基线到1个月的DHI变化不显著。与对照组相比,粘附屏障组在2周时的语音障碍指数评分明显增加较小(氧化再生纤维素:平均(s.d) 4.8(5.8);高分子量透明质酸:0.8(6.3);控制:8.4 (9.6);P = 0.032)和1个月时分别为3.0(5.2)、1.0(7.1)和9.1(12.3);P = 0.047)。吞咽障碍评分的变化在黏附屏障组明显较低(2.1(5.6)比6.0(5.9);P = 0.037),但三组间无显著差异(氧化再生纤维素:1.4(4.2);高分子量透明质酸:2.8(6.8);控制:6.0 (5.9);P = 0.095)。与氧化再生纤维素组(P = 0.041)相比,高分子量透明质酸组在1个月时表现出更好的喉气管抬高保存(P = 0.006)。未见粘连障碍相关并发症。到6个月时,所有组的大多数参数都恢复到接近基线水平。结论:氧化再生纤维素和高分子量透明质酸在减轻甲状腺切除术后早期粘连症状方面都是安全有效的,其中高分子量透明质酸在某些指标上表现出更好的效果。这些发现支持在甲状腺手术中使用粘连屏障,尽管需要更大规模的研究来证实其长期效益。注册号:NCT05851560 (http://www.clinicaltrials.gov)。
{"title":"Post-thyroid surgery adhesion prevention using oxidized regenerated cellulose and hyaluronic acid: prospective, single-blinded, randomized study.","authors":"Ting-Chun Kuo, Kuen-Yuan Chen, Yi-Jhih Tsai, Ming-Tsan Lin, Chin-Hao Chang, Ming-Hsun Wu","doi":"10.1093/bjsopen/zraf079","DOIUrl":"10.1093/bjsopen/zraf079","url":null,"abstract":"<p><strong>Background: </strong>Postoperative adhesions following thyroidectomy significantly affect patient quality of life, yet prevention strategies remain understudied. This trial evaluated the safety and efficacy of oxidized regenerated cellulose and high molecular weight hyaluronic acid in preventing post-thyroidectomy adhesions.</p><p><strong>Methods: </strong>In this prospective, single-blinded, randomized study, patients undergoing thyroidectomy were randomized 1 : 1 : 1 to receive oxidized regenerated cellulose (Interceed™), high molecular weight hyaluronic acid (HANBIO BarriGel), or no adhesion barrier (control). The primary outcome was change in the Dysphagia Handicap Index (DHI) from baseline to 1 month. Secondary outcomes included the Voice Handicap Index, Swallowing Impairment Score, laryngotracheal elevation, and adhesion severity scores at 2 weeks, and 1, 6, and 12 months after operation.</p><p><strong>Results: </strong>Forty -five patients were enrolled. Changes in DHI were not significant from baseline to 1 month among the three groups. The adhesion barrier groups demonstrated significantly smaller increases in Voice Handicap Index scores compared with the control group at 2 weeks (oxidized regenerated cellulose: mean(s.d.) 4.8(5.8); high molecular weight hyaluronic acid: 0.8(6.3); control: 8.4(9.6); P = 0.032) and at 1 month (3.0(5.2), 1.0(7.1), and 9.1(12.3), respectively; P = 0.047). Changes in Swallowing Impairment Scores were significantly lower in the adhesion barrier groups (2.1(5.6) versus 6.0(5.9); P = 0.037), although no significant differences were observed among the three groups (oxidized regenerated cellulose: 1.4(4.2); high molecular weight hyaluronic acid: 2.8(6.8); control: 6.0(5.9); P = 0.095) at 2 weeks. The high molecular weight hyaluronic acid group demonstrated superior preservation of laryngotracheal elevation among groups (P = 0.006) and compared with the oxidized regenerated cellulose group (P = 0.041) at 1 month. No adhesion barrier-related complications were observed. By 6 months, most parameters had returned to near-baseline levels across all groups.</p><p><strong>Conclusion: </strong>Both oxidized regenerated cellulose and high molecular weight hyaluronic acid appear safe and potentially effective in reducing early post-thyroidectomy adhesion symptoms, with high molecular weight hyaluronic acid showing superior outcomes in certain parameters. These findings support the use of adhesion barriers in thyroid surgery, although larger studies are needed to confirm their long-term benefits.</p><p><strong>Registration number: </strong>NCT05851560 (http://www.clinicaltrials.gov).</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"9 4","pages":""},"PeriodicalIF":4.5,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12231606/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144558975","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Time to recovery following open and endoscopic carpal tunnel decompression: meta-analysis. 开放和内窥镜腕管减压术后恢复时间:meta分析。
IF 4.5 3区 医学 Q1 SURGERY Pub Date : 2025-07-01 DOI: 10.1093/bjsopen/zraf085
Olivia J Hartrick, Rebecca K Turner, Alexander Freethy, Chetan Khatri, Lauren Chong, Ryckie G Wade, Justin C R Wormald, Akira Wiberg, Jeremy N Rodrigues, Conrad Harrison

Background: Carpal tunnel release (CTR) can be performed using either an open or endoscopic approach. The patient recovery trajectories remain poorly understood. This study aimed to define and compare patient-reported recovery following unilateral open and endoscopic CTR.

Methods: A PRISMA-compliant, preregistered (CRD42023427718) systematic review was conducted, searching PubMed, Embase, and Cochrane databases on 4 July 2023 and 21 August 2024. Studies were included if they reported recovery data (patient-reported outcome measures (PROMs)) at predefined time points for adults undergoing unilateral CTR. Boston Carpal Tunnel Questionnaire and Quick Disabilities of Arm, Shoulder, and Hand scores were extracted. Standardized mean change (SMC) scores from baseline were pooled using random-effects meta-analysis. An innovative modification of the National Institutes of Health quality assessment tools was used to evaluate the risk of bias.

Results: In all, 49 studies were included (4546 participants included in the analysis; 3137 open CTR, 1409 endoscopic CTR). Both approaches improved PROM scores over 12 weeks, with early (4-week) outcomes strongly correlating (>0.89) with later (12-week) outcomes. Symptoms continued improving up to 104 weeks. At 1 week, open CTR showed symptomatic deterioration (SMC 10.29; 95% confidence interval (c.i.) 6.35 and 14.21 respectively), comparatively, endoscopic CTR demonstrated an improvement (SMC -2.83; 95% c.i. -7.80 and 2.14 respectively). By 2 weeks, symptom severity remained slightly worse in open CTR, but confidence intervals overlapped from week 3 and thereafter open CTR showed greater symptomatic improvement. Most studies had a high risk of bias and measured outcomes too infrequently for a granular comparison.

Conclusions: Patient-reported recovery trajectories for CTR can inform patient counselling and future research. Endoscopic CTR may result in fewer symptoms in the first 2 weeks, but open CTR may offer comparable or potentially greater improvement thereafter. Future trials with high-frequency PROM capture should prioritize early (first 3 weeks) and long-term (≥24 weeks) outcomes.

背景:腕管释放术(CTR)可以通过开放或内窥镜入路进行。病人的康复轨迹仍然知之甚少。本研究旨在定义和比较单侧开放CTR和内窥镜CTR后患者报告的恢复情况。方法:于2023年7月4日和2024年8月21日检索PubMed、Embase和Cochrane数据库,进行符合prisma标准的预注册(CRD42023427718)系统评价。如果研究报告了在预定时间点接受单侧CTR的成年人的恢复数据(患者报告的结果测量(PROMs)),则纳入研究。提取波士顿腕管问卷和手臂、肩膀和手的快速残疾评分。采用随机效应荟萃分析对基线的标准化平均变化(SMC)评分进行汇总。对美国国立卫生研究院质量评估工具进行了创新性修改,用于评估偏倚风险。结果:共纳入49项研究(4546名受试者纳入分析;3137开放式CTR, 1409内窥镜CTR)。两种方法在12周内都提高了PROM评分,早期(4周)结果与后期(12周)结果强烈相关(>.89)。症状持续改善至104周。1周时,开放CTR显示症状恶化(SMC 10.29;95%可信区间(ci)分别为6.35和14.21),相比之下,内镜下CTR表现出改善(SMC -2.83;95% c.i.分别为-7.80和2.14)。到2周时,开放CTR组的症状严重程度仍略差,但从第3周开始可信区间重叠,此后开放CTR显示出更大的症状改善。大多数研究存在较高的偏倚风险,而且测量结果的频率太低,无法进行细粒度比较。结论:患者报告的CTR恢复轨迹可以为患者咨询和未来的研究提供信息。内镜下CTR可能在前两周导致较少的症状,但开放CTR可能在此后提供类似或潜在更大的改善。未来的高频早膜捕获试验应优先考虑早期(前3周)和长期(≥24周)的结果。
{"title":"Time to recovery following open and endoscopic carpal tunnel decompression: meta-analysis.","authors":"Olivia J Hartrick, Rebecca K Turner, Alexander Freethy, Chetan Khatri, Lauren Chong, Ryckie G Wade, Justin C R Wormald, Akira Wiberg, Jeremy N Rodrigues, Conrad Harrison","doi":"10.1093/bjsopen/zraf085","DOIUrl":"10.1093/bjsopen/zraf085","url":null,"abstract":"<p><strong>Background: </strong>Carpal tunnel release (CTR) can be performed using either an open or endoscopic approach. The patient recovery trajectories remain poorly understood. This study aimed to define and compare patient-reported recovery following unilateral open and endoscopic CTR.</p><p><strong>Methods: </strong>A PRISMA-compliant, preregistered (CRD42023427718) systematic review was conducted, searching PubMed, Embase, and Cochrane databases on 4 July 2023 and 21 August 2024. Studies were included if they reported recovery data (patient-reported outcome measures (PROMs)) at predefined time points for adults undergoing unilateral CTR. Boston Carpal Tunnel Questionnaire and Quick Disabilities of Arm, Shoulder, and Hand scores were extracted. Standardized mean change (SMC) scores from baseline were pooled using random-effects meta-analysis. An innovative modification of the National Institutes of Health quality assessment tools was used to evaluate the risk of bias.</p><p><strong>Results: </strong>In all, 49 studies were included (4546 participants included in the analysis; 3137 open CTR, 1409 endoscopic CTR). Both approaches improved PROM scores over 12 weeks, with early (4-week) outcomes strongly correlating (>0.89) with later (12-week) outcomes. Symptoms continued improving up to 104 weeks. At 1 week, open CTR showed symptomatic deterioration (SMC 10.29; 95% confidence interval (c.i.) 6.35 and 14.21 respectively), comparatively, endoscopic CTR demonstrated an improvement (SMC -2.83; 95% c.i. -7.80 and 2.14 respectively). By 2 weeks, symptom severity remained slightly worse in open CTR, but confidence intervals overlapped from week 3 and thereafter open CTR showed greater symptomatic improvement. Most studies had a high risk of bias and measured outcomes too infrequently for a granular comparison.</p><p><strong>Conclusions: </strong>Patient-reported recovery trajectories for CTR can inform patient counselling and future research. Endoscopic CTR may result in fewer symptoms in the first 2 weeks, but open CTR may offer comparable or potentially greater improvement thereafter. Future trials with high-frequency PROM capture should prioritize early (first 3 weeks) and long-term (≥24 weeks) outcomes.</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"9 4","pages":""},"PeriodicalIF":4.5,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12284922/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144688858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of sarcopenia and myosteatosis to determine the impact on mortality after emergency laparotomy. 评估紧急剖腹手术后肌肉减少症和骨骼肌病对死亡率的影响。
IF 4.5 3区 医学 Q1 SURGERY Pub Date : 2025-07-01 DOI: 10.1093/bjsopen/zraf092
Richard P T Evans, Dimit Raveshia, Mei Sien Liew, Anna Jackowski, Aaron Kisiel, Ewen A Griffiths, Benjamin H L Tan

Background: Emergency laparotomy is performed for a wide range of life-threatening conditions and is associated with significant morbidity and mortality. Risk prediction models facilitate accurate communication of operative risk with patients and relatives, in addition to benchmarking unit outcomes. Greater understanding of the impact of sarcopenia or myosteatosis will encourage the adoption of routine radiological reporting of body composition and the incorporation of skeletal muscle gauge (SMG) into risk prediction models. This study investigated the prognostic significance of SMG, an aggregate assessment of sarcopenia or myosteatosis, in patients who had undergone an emergency non-trauma-related laparotomy.

Methods: This was a retrospective cohort study of patients aged ≥ 18 years who underwent an emergency laparotomy at the Queen Elizabeth Hospital between January 2014 and December 2020. Body composition and patient outcomes were analysed.

Results: In all, 1090 patients with a mean(standard deviation) age of 62.3(17.5) years underwent emergency laparotomy (bowel obstruction, 52.7%; perforation, 26.3%; ischaemia, 9.5%). Overall 30- and 90-day mortality was 10.0% and 11.6%, respectively. On multivariate analysis, low SMG was associated with worse 30- and 90-day mortality, with odds ratios of 2.12 (95% confidence interval (c.i.) 1.18 to 3.83; P = 0.012) and 2.64 (95% c.i. 1.55 to 4.48; P < 0.001), respectively. Low SMG was also associated with an increased length of hospital stay (odds ratio 1.45; 95% c.i. 1.22 to 1.72; P < 0.001).

Conclusion: A low SMG was associated with increased postoperative mortality and length of hospital stay after emergency laparotomy. Patients undergoing computed tomography imaging for acute abdominal pain should undergo routine reporting of body composition.

背景:急诊剖腹手术适用于各种危及生命的情况,并与显著的发病率和死亡率相关。风险预测模型有助于与患者和家属准确沟通手术风险,以及对单位结果进行基准测试。更深入地了解肌肉减少症或骨骼肌病的影响将鼓励采用常规的身体成分放射学报告,并将骨骼肌测量(SMG)纳入风险预测模型。本研究探讨了SMG的预后意义,SMG是一种对紧急非创伤性剖腹手术患者肌肉减少症或肌骨化症的综合评估。方法:这是一项回顾性队列研究,纳入了2014年1月至2020年12月期间在伊丽莎白女王医院接受紧急剖腹手术的年龄≥18岁的患者。分析患者的身体成分和预后。结果:共有1090例患者接受了紧急剖腹手术,平均(标准差)年龄为62.3(17.5)岁(肠梗阻,52.7%;穿孔,26.3%;局部贫血,9.5%)。总体30天和90天死亡率分别为10.0%和11.6%。在多变量分析中,低SMG与较差的30天和90天死亡率相关,比值比为2.12(95%可信区间(ci) 1.18至3.83;P = 0.012)和2.64 (95% ci: 1.55 ~ 4.48;P < 0.001)。低SMG也与住院时间延长相关(优势比1.45;95% ci为1.22至1.72;P < 0.001)。结论:低SMG与急诊剖腹手术术后死亡率和住院时间增加有关。因急性腹痛接受计算机断层成像的患者应常规报告身体成分。
{"title":"Evaluation of sarcopenia and myosteatosis to determine the impact on mortality after emergency laparotomy.","authors":"Richard P T Evans, Dimit Raveshia, Mei Sien Liew, Anna Jackowski, Aaron Kisiel, Ewen A Griffiths, Benjamin H L Tan","doi":"10.1093/bjsopen/zraf092","DOIUrl":"10.1093/bjsopen/zraf092","url":null,"abstract":"<p><strong>Background: </strong>Emergency laparotomy is performed for a wide range of life-threatening conditions and is associated with significant morbidity and mortality. Risk prediction models facilitate accurate communication of operative risk with patients and relatives, in addition to benchmarking unit outcomes. Greater understanding of the impact of sarcopenia or myosteatosis will encourage the adoption of routine radiological reporting of body composition and the incorporation of skeletal muscle gauge (SMG) into risk prediction models. This study investigated the prognostic significance of SMG, an aggregate assessment of sarcopenia or myosteatosis, in patients who had undergone an emergency non-trauma-related laparotomy.</p><p><strong>Methods: </strong>This was a retrospective cohort study of patients aged ≥ 18 years who underwent an emergency laparotomy at the Queen Elizabeth Hospital between January 2014 and December 2020. Body composition and patient outcomes were analysed.</p><p><strong>Results: </strong>In all, 1090 patients with a mean(standard deviation) age of 62.3(17.5) years underwent emergency laparotomy (bowel obstruction, 52.7%; perforation, 26.3%; ischaemia, 9.5%). Overall 30- and 90-day mortality was 10.0% and 11.6%, respectively. On multivariate analysis, low SMG was associated with worse 30- and 90-day mortality, with odds ratios of 2.12 (95% confidence interval (c.i.) 1.18 to 3.83; P = 0.012) and 2.64 (95% c.i. 1.55 to 4.48; P < 0.001), respectively. Low SMG was also associated with an increased length of hospital stay (odds ratio 1.45; 95% c.i. 1.22 to 1.72; P < 0.001).</p><p><strong>Conclusion: </strong>A low SMG was associated with increased postoperative mortality and length of hospital stay after emergency laparotomy. Patients undergoing computed tomography imaging for acute abdominal pain should undergo routine reporting of body composition.</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"9 4","pages":""},"PeriodicalIF":4.5,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12341672/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144833916","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Topical tranexamic acid in mastectomies on haematoma formation: prospective cohort study. 局部氨甲环酸对乳房切除术中血肿形成的影响:前瞻性队列研究。
IF 4.5 3区 医学 Q1 SURGERY Pub Date : 2025-07-01 DOI: 10.1093/bjsopen/zraf081
Ali Raed Buheiri, Louise Tveskov, Laura Marie Dines, Josephine Dissing Bagge, Sören Möller, Camilla Bille

Background: Reports suggest tranexamic acid (TXA) reduces haematoma formation after breast surgery. This study investigated the effects of postoperative retrograde instillation of topical TXA through surgical drains on postoperative haematoma formation requiring surgical intervention and drain output 24 hours after mastectomy procedures.

Methods: A prospective cohort study was conducted from October 2020 until September 2023, comprising two consecutive periods. In the first period, women underwent mastectomy without receiving TXA (control); in the second, women received retrograde instillation of 20 ml of 50 mg/ml TXA into the drain immediately after cavity closure. This was performed as part of a change in routine practice in April 2023. Primary endpoints collected from patient medical records were haematoma formation requiring surgical intervention, mean drain output 24 hours after the procedure, and thromboembolic events. Type of surgery, age, body mass index, smoking status, the use of blood thinners, neoadjuvant therapy, and the indication for surgery were considered patient variables that could potentially affect primary endpoints. Regression analysis was used to analyse relationships between TXA administration and haematoma occurrence and drain output, adjusting for the specified patient variables. This study was designed in accordance with STROBE guidelines.

Results: Among 297 breasts (271 women) receiving topical TXA and 278 breasts (264 women) in the control group, 4 (1%) and 19 (7%) breasts, respectively, had surgical revisions due to haematoma (P = 0.003). Drain output within the first 24 hours after the procedure was significantly lower in the TXA than control group (mean(standard deviation) 67.6(62.4) versus 103.9(106.6) ml, respectively; P < 0.001). No thromboembolic events were reported. Women in the control group had a higher body mass index and mean age, and a higher proportion underwent axillary clearance and received neoadjuvant therapy compared with the TXA group. A higher proportion of women in the TXA group underwent sentinel node biopsy. After adjusting for these variables, significant differences remained between the two groups in haematoma rate (P = 0.005) and drain output (P = 0.001).

Conclusion: Retrograde administration of 20 ml of 50 mg/ml topical TXA into the cavity after mastectomy significantly reduced the incidence of haematoma formation and drain output within the first 24 hours.

背景:报告显示氨甲环酸(TXA)减少乳房手术后血肿的形成。本研究探讨了术后通过手术引流管逆行灌注局部TXA对需要手术干预的术后血肿形成和乳房切除术后24小时引流管输出的影响。方法:一项前瞻性队列研究于2020年10月至2023年9月进行,包括连续两个时期。在第一阶段,接受乳房切除术的妇女没有接受TXA(对照组);在第二组中,女性在腔关闭后立即向排水管中逆行灌注20毫升50毫克/毫升的TXA。这是2023年4月例行实践变化的一部分。从患者医疗记录中收集的主要终点是血肿形成需要手术干预,手术后24小时的平均引流量和血栓栓塞事件。手术类型、年龄、体重指数、吸烟状况、血液稀释剂的使用、新辅助治疗和手术指征被认为是可能影响主要终点的患者变量。采用回归分析分析TXA给药与血肿发生和引流量之间的关系,并对特定的患者变量进行调整。本研究按照STROBE指南设计。结果:在局部应用TXA的297个乳房(271名女性)和对照组278个乳房(264名女性)中,分别有4个(1%)和19个(7%)乳房因血肿进行了手术修复(P = 0.003)。术后24小时内排液量明显低于对照组(平均(标准差)分别为67.6(62.4)ml和103.9(106.6)ml;P < 0.001)。无血栓栓塞事件报道。与TXA组相比,对照组女性的体重指数和平均年龄更高,接受腋窝清除率和新辅助治疗的比例更高。TXA组接受前哨淋巴结活检的女性比例较高。在调整这些变量后,两组在血肿率(P = 0.005)和引流量(P = 0.001)方面仍有显著差异。结论:乳房切除术后腔内逆行给予20 ml 50 mg/ml的局部TXA,可显著降低术后24小时内血肿形成的发生率和排液量。
{"title":"Topical tranexamic acid in mastectomies on haematoma formation: prospective cohort study.","authors":"Ali Raed Buheiri, Louise Tveskov, Laura Marie Dines, Josephine Dissing Bagge, Sören Möller, Camilla Bille","doi":"10.1093/bjsopen/zraf081","DOIUrl":"10.1093/bjsopen/zraf081","url":null,"abstract":"<p><strong>Background: </strong>Reports suggest tranexamic acid (TXA) reduces haematoma formation after breast surgery. This study investigated the effects of postoperative retrograde instillation of topical TXA through surgical drains on postoperative haematoma formation requiring surgical intervention and drain output 24 hours after mastectomy procedures.</p><p><strong>Methods: </strong>A prospective cohort study was conducted from October 2020 until September 2023, comprising two consecutive periods. In the first period, women underwent mastectomy without receiving TXA (control); in the second, women received retrograde instillation of 20 ml of 50 mg/ml TXA into the drain immediately after cavity closure. This was performed as part of a change in routine practice in April 2023. Primary endpoints collected from patient medical records were haematoma formation requiring surgical intervention, mean drain output 24 hours after the procedure, and thromboembolic events. Type of surgery, age, body mass index, smoking status, the use of blood thinners, neoadjuvant therapy, and the indication for surgery were considered patient variables that could potentially affect primary endpoints. Regression analysis was used to analyse relationships between TXA administration and haematoma occurrence and drain output, adjusting for the specified patient variables. This study was designed in accordance with STROBE guidelines.</p><p><strong>Results: </strong>Among 297 breasts (271 women) receiving topical TXA and 278 breasts (264 women) in the control group, 4 (1%) and 19 (7%) breasts, respectively, had surgical revisions due to haematoma (P = 0.003). Drain output within the first 24 hours after the procedure was significantly lower in the TXA than control group (mean(standard deviation) 67.6(62.4) versus 103.9(106.6) ml, respectively; P < 0.001). No thromboembolic events were reported. Women in the control group had a higher body mass index and mean age, and a higher proportion underwent axillary clearance and received neoadjuvant therapy compared with the TXA group. A higher proportion of women in the TXA group underwent sentinel node biopsy. After adjusting for these variables, significant differences remained between the two groups in haematoma rate (P = 0.005) and drain output (P = 0.001).</p><p><strong>Conclusion: </strong>Retrograde administration of 20 ml of 50 mg/ml topical TXA into the cavity after mastectomy significantly reduced the incidence of haematoma formation and drain output within the first 24 hours.</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"9 4","pages":""},"PeriodicalIF":4.5,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12312098/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144752256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Use of artificial intelligence in the analysis of digital videos of invasive surgical procedures: scoping review. 人工智能在侵入性外科手术数字视频分析中的应用:范围审查。
IF 3.5 3区 医学 Q1 SURGERY Pub Date : 2025-07-01 DOI: 10.1093/bjsopen/zraf073
Anni King, George E Fowler, Rhiannon C Macefield, Hamish Walker, Charlie Thomas, Sheraz Markar, Ethan Higgins, Jane M Blazeby, Natalie S Blencowe

Introduction: Surgical videos are a valuable data source, offering detailed insights into surgical practice. However, video analysis requires specialist clinical knowledge and takes considerable time. Artificial intelligence (AI) has the potential to improve and streamline the interpretation of intraoperative video data. This systematic scoping review aimed to summarize the use of AI in the analysis of videos of surgical procedures and identify evidence gaps.

Methods: Systematic searches of Ovid MEDLINE and Embase were performed using search terms 'artificial intelligence', 'video', and 'surgery'. Data extraction included reporting of general study characteristics; the overall objective of AI; descriptions of data sets, AI models, and training; methods of data annotation; and measures of accuracy. Data were summarized descriptively.

Results: In all, 122 studies were included. More than half focused on gastrointestinal procedures (75 studies, 61.5%), predominantly cholecystectomy (47, 38.5%). The most common objectives were surgical phase recognition (40 studies, 32.8%), surgical instrument recognition (28, 23.0%), and enhanced intraoperative visualization (23, 18.9%). Of the studies, 79.5% (97) used a single data set and most (92, 75.4%) used supervised machine learning techniques. There was considerable variation across the studies in terms of the number of videos, centres, and contributing surgeons. Forty-seven studies (38.5%) did not report the number of annotators, and details about their experience were frequently omitted (102, 83.6%). Most studies used multiple outcome measures (67, 54.9%), most commonly overall or best accuracy of the AI model (67, 54.9%).

Conclusion: This review found that many studies omitted essential methodological details of AI training, testing, data annotation, and validation processes, creating difficulties when interpreting and replicating these studies. Another key finding was the lack of large data sets from multiple centres and surgeons. Future research should focus on curating large, varied, open-access data sets from multiple centres, patients, and surgeons to facilitate accurate evaluation using real-world data.

手术视频是一个有价值的数据源,提供详细的见解手术实践。然而,视频分析需要专业的临床知识,并且需要相当长的时间。人工智能(AI)具有改进和简化术中视频数据解释的潜力。本系统的范围综述旨在总结人工智能在外科手术视频分析中的应用,并确定证据差距。方法:系统检索Ovid MEDLINE和Embase,检索词为“人工智能”、“视频”和“外科”。数据提取包括一般研究特征的报告;人工智能的总体目标;数据集、人工智能模型和训练的描述;数据标注方法;以及准确性的度量。对数据进行描述性总结。结果:共纳入122项研究。超过一半的研究集中在胃肠手术(75项研究,61.5%),主要是胆囊切除术(47项,38.5%)。最常见的目标是手术阶段识别(40项研究,32.8%),手术器械识别(28项,23.0%)和增强术中可视化(23项,18.9%)。在这些研究中,79.5%(97)使用了单个数据集,大多数(92,75.4%)使用了监督式机器学习技术。这些研究在视频、中心和参与手术的外科医生的数量方面存在相当大的差异。47项研究(38.5%)没有报告注释者的数量,并且经常遗漏注释者的经验细节(102,83.6%)。大多数研究使用多个结果测量(67,54.9%),最常见的是人工智能模型的总体或最佳准确性(67,54.9%)。结论:本综述发现,许多研究忽略了人工智能训练、测试、数据注释和验证过程的基本方法学细节,给解释和复制这些研究带来了困难。另一个重要发现是缺乏来自多个中心和外科医生的大型数据集。未来的研究应侧重于整理来自多个中心、患者和外科医生的大型、多样、开放获取的数据集,以促进使用真实世界数据的准确评估。
{"title":"Use of artificial intelligence in the analysis of digital videos of invasive surgical procedures: scoping review.","authors":"Anni King, George E Fowler, Rhiannon C Macefield, Hamish Walker, Charlie Thomas, Sheraz Markar, Ethan Higgins, Jane M Blazeby, Natalie S Blencowe","doi":"10.1093/bjsopen/zraf073","DOIUrl":"10.1093/bjsopen/zraf073","url":null,"abstract":"<p><strong>Introduction: </strong>Surgical videos are a valuable data source, offering detailed insights into surgical practice. However, video analysis requires specialist clinical knowledge and takes considerable time. Artificial intelligence (AI) has the potential to improve and streamline the interpretation of intraoperative video data. This systematic scoping review aimed to summarize the use of AI in the analysis of videos of surgical procedures and identify evidence gaps.</p><p><strong>Methods: </strong>Systematic searches of Ovid MEDLINE and Embase were performed using search terms 'artificial intelligence', 'video', and 'surgery'. Data extraction included reporting of general study characteristics; the overall objective of AI; descriptions of data sets, AI models, and training; methods of data annotation; and measures of accuracy. Data were summarized descriptively.</p><p><strong>Results: </strong>In all, 122 studies were included. More than half focused on gastrointestinal procedures (75 studies, 61.5%), predominantly cholecystectomy (47, 38.5%). The most common objectives were surgical phase recognition (40 studies, 32.8%), surgical instrument recognition (28, 23.0%), and enhanced intraoperative visualization (23, 18.9%). Of the studies, 79.5% (97) used a single data set and most (92, 75.4%) used supervised machine learning techniques. There was considerable variation across the studies in terms of the number of videos, centres, and contributing surgeons. Forty-seven studies (38.5%) did not report the number of annotators, and details about their experience were frequently omitted (102, 83.6%). Most studies used multiple outcome measures (67, 54.9%), most commonly overall or best accuracy of the AI model (67, 54.9%).</p><p><strong>Conclusion: </strong>This review found that many studies omitted essential methodological details of AI training, testing, data annotation, and validation processes, creating difficulties when interpreting and replicating these studies. Another key finding was the lack of large data sets from multiple centres and surgeons. Future research should focus on curating large, varied, open-access data sets from multiple centres, patients, and surgeons to facilitate accurate evaluation using real-world data.</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"9 4","pages":""},"PeriodicalIF":3.5,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12268333/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144648447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Outcomes of inflammatory bowel disease in patients with obesity following bariatric surgery: propensity score-matched cohort study. 减肥手术后肥胖患者炎症性肠病的结局:倾向评分匹配队列研究
IF 4.5 3区 医学 Q1 SURGERY Pub Date : 2025-07-01 DOI: 10.1093/bjsopen/zraf086
Erik Stenberg, Åsa H Everhov, Jonas Söderling, Johan Ottosson, Mehdi Osooli, Ellen Andersson, Daniel Bergemalm, Jonas F Ludvigsson, Carl Eriksson, Ola Olén

Background: Obesity is increasing among patients with inflammatory bowel disease, but bariatric surgery has been rare in this group owing to concerns about worsening the inflammatory bowel disease. The aim of the study was to evaluate inflammatory bowel disease-related outcomes following bariatric surgery.

Methods: Nationwide cohort of all adult patients in Sweden between 2007 and 2020 with obesity and inflammatory bowel disease. Patients were matched 1 : 1 with a two-stage matching process between those undergoing bariatric surgery with those who did not (classified by inflammatory bowel disease subtype followed by a propensity score match including sex, age, number of previous targeted therapies, presence of immunotherapy, cumulative oral corticosteroid dose, and previous intestinal surgery). The primary composite outcome comprised inflammatory bowel disease-related hospitalization, initiation of corticosteroid therapy, immunomodulation, commencement of a new targeted therapy or major inflammatory bowel disease-related surgery.

Results: The study included 798 patients with inflammatory bowel disease and obesity: 399 who underwent bariatric surgery (145 Crohn's disease, 238 ulcerative colitis, 16 unclassified inflammatory bowel disease) versus 399 who did not. Over a median observation period of 3.3 years in the surgery group and 3.0 years in the non-surgery group, the composite primary endpoint occurred in 201 patients who had surgery (incidence rate 11.9 (95% confidence interval (c.i.) 10.2 to 13.5) per 100 person-years) and 226 without surgery (incidence rate 15.1 (13.1 to 17.0) per 100 person-years), corresponding to an adjusted hazard ratio of 0.66 (95% c.i. 0.51 to 0.85) in those undergoing bariatric surgery compared with those who did not.

Conclusion: Bariatric surgery was associated with improved inflammatory bowel disease-related outcomes among patients with inflammatory bowel disease and obesity, suggesting a potential benefit from bariatric surgery among patients with concomitant obesity and inflammatory bowel disease.

背景:炎症性肠病患者的肥胖正在增加,但由于担心炎症性肠病恶化,这一群体很少进行减肥手术。该研究的目的是评估减肥手术后炎症性肠病相关的结果。方法:瑞典2007年至2020年间患有肥胖和炎症性肠病的所有成年患者的全国队列。患者在接受减肥手术的患者与未接受减肥手术的患者之间进行1:1的两阶段匹配过程(根据炎症性肠病亚型分类,然后进行倾向评分匹配,包括性别、年龄、既往靶向治疗次数、存在免疫治疗、累计口服皮质类固醇剂量和既往肠道手术)。主要综合结果包括炎症性肠病相关住院治疗、开始皮质类固醇治疗、免疫调节、开始新的靶向治疗或主要炎症性肠病相关手术。结果:该研究包括798例炎症性肠病和肥胖症患者:399例接受了减肥手术(145例克罗恩病,238例溃疡性结肠炎,16例未分类炎症性肠病),399例未接受手术。值观察一段手术组3.3年和3.0年的非手术集团复合主要终点发生在201年患者手术(发病率11.9(95%置信区间(c.i。)10.2到13.5)每100人年)和226年没有手术(发病率15.1(13.1 - 17.0)每100人每年),对应于一个调整风险比为0.66 (95% c.i。0.51到0.85)在那些接受减肥手术相比之下,那些没有。结论:在炎症性肠病和肥胖患者中,减肥手术与炎症性肠病相关结局的改善相关,表明在伴有肥胖和炎症性肠病的患者中,减肥手术具有潜在的益处。
{"title":"Outcomes of inflammatory bowel disease in patients with obesity following bariatric surgery: propensity score-matched cohort study.","authors":"Erik Stenberg, Åsa H Everhov, Jonas Söderling, Johan Ottosson, Mehdi Osooli, Ellen Andersson, Daniel Bergemalm, Jonas F Ludvigsson, Carl Eriksson, Ola Olén","doi":"10.1093/bjsopen/zraf086","DOIUrl":"10.1093/bjsopen/zraf086","url":null,"abstract":"<p><strong>Background: </strong>Obesity is increasing among patients with inflammatory bowel disease, but bariatric surgery has been rare in this group owing to concerns about worsening the inflammatory bowel disease. The aim of the study was to evaluate inflammatory bowel disease-related outcomes following bariatric surgery.</p><p><strong>Methods: </strong>Nationwide cohort of all adult patients in Sweden between 2007 and 2020 with obesity and inflammatory bowel disease. Patients were matched 1 : 1 with a two-stage matching process between those undergoing bariatric surgery with those who did not (classified by inflammatory bowel disease subtype followed by a propensity score match including sex, age, number of previous targeted therapies, presence of immunotherapy, cumulative oral corticosteroid dose, and previous intestinal surgery). The primary composite outcome comprised inflammatory bowel disease-related hospitalization, initiation of corticosteroid therapy, immunomodulation, commencement of a new targeted therapy or major inflammatory bowel disease-related surgery.</p><p><strong>Results: </strong>The study included 798 patients with inflammatory bowel disease and obesity: 399 who underwent bariatric surgery (145 Crohn's disease, 238 ulcerative colitis, 16 unclassified inflammatory bowel disease) versus 399 who did not. Over a median observation period of 3.3 years in the surgery group and 3.0 years in the non-surgery group, the composite primary endpoint occurred in 201 patients who had surgery (incidence rate 11.9 (95% confidence interval (c.i.) 10.2 to 13.5) per 100 person-years) and 226 without surgery (incidence rate 15.1 (13.1 to 17.0) per 100 person-years), corresponding to an adjusted hazard ratio of 0.66 (95% c.i. 0.51 to 0.85) in those undergoing bariatric surgery compared with those who did not.</p><p><strong>Conclusion: </strong>Bariatric surgery was associated with improved inflammatory bowel disease-related outcomes among patients with inflammatory bowel disease and obesity, suggesting a potential benefit from bariatric surgery among patients with concomitant obesity and inflammatory bowel disease.</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"9 4","pages":""},"PeriodicalIF":4.5,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12345414/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144844298","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Liver transplantation as a treatment for cancer: comprehensive review. 肝移植作为一种治疗癌症的方法:综合综述。
IF 3.5 3区 医学 Q1 SURGERY Pub Date : 2025-05-07 DOI: 10.1093/bjsopen/zraf034
Bobby V M Dasari, Pal-Dag Line, Gonzalo Sapisochin, Taizo Hibi, Prashant Bhangui, Karim J Halazun, Shishir Shetty, Tahir Shah, Christian T J Magyar, Conor Donnelly, Dev Chatterjee

Background: Liver transplantation for cancer indications has gained momentum in recent years. This review is intended to optimize the care setting of liver transplant candidates by highlighting current indications, technical aspects and barriers with available solutions to facilitate the guidance of available strategies for healthcare professionals in specialized centres.

Methods: A review of the most recent relevant literature was conducted for all the cancer indications of liver transplantation including colorectal cancer liver metastases, hilar cholangiocarcinoma, intrahepatic cholangiocarcinoma, neuroendocrine tumours, hepatocellular carcinoma and hepatic epitheloid haemangioendothelioma.

Results: Transplant benefit from the best available evidence, including SECA I, SECA II, TRANSMET studies for colorectal liver metastases, various preoperative protocols for cholangiocarcinoma patients, standard, extended selection criteria for hepatocellular carcinoma and neuroendocrine tumours, are discussed. Innovative approaches to deal with organ shortages, including machine-perfused deceased grafts, living donor liver transplantation and RAPID procedures, are also explored.

Conclusion: Cancer indications for liver transplantation are here to stay, and the selection criteria among all cancer groups are likely to evolve further with improved prognostication of tumour biology using adjuncts such as radiomics, cancer genomics, and circulating DNA and RNA status. International prospective registry-based studies could overcome the limitations of smaller patient cohorts and lack of level 1 evidence.

背景:近年来,针对癌症适应症的肝移植越来越多。本综述旨在通过强调当前适应症、技术方面和现有解决方案的障碍来优化肝移植候选人的护理环境,以促进专业中心医疗保健专业人员的可用策略指导。方法:对结直肠癌肝转移、肝门部胆管癌、肝内胆管癌、神经内分泌肿瘤、肝细胞癌、肝上皮血管内皮瘤等所有肝移植的指征进行最新的相关文献回顾。结果:移植受益于现有的最佳证据,包括SECA I, SECA II,结肠直肠癌肝转移的TRANSMET研究,胆管癌患者的各种术前方案,肝细胞癌和神经内分泌肿瘤的标准,扩展选择标准,讨论。还探讨了处理器官短缺的创新方法,包括机器灌注的死者移植物,活体供体肝移植和RAPID程序。结论:肝移植的癌症适应症将继续存在,随着肿瘤生物学预后的改善,使用放射组学、癌症基因组学和循环DNA和RNA状态等辅助手段,所有癌症组的选择标准可能会进一步发展。国际前瞻性注册研究可以克服较小患者队列和缺乏一级证据的局限性。
{"title":"Liver transplantation as a treatment for cancer: comprehensive review.","authors":"Bobby V M Dasari, Pal-Dag Line, Gonzalo Sapisochin, Taizo Hibi, Prashant Bhangui, Karim J Halazun, Shishir Shetty, Tahir Shah, Christian T J Magyar, Conor Donnelly, Dev Chatterjee","doi":"10.1093/bjsopen/zraf034","DOIUrl":"10.1093/bjsopen/zraf034","url":null,"abstract":"<p><strong>Background: </strong>Liver transplantation for cancer indications has gained momentum in recent years. This review is intended to optimize the care setting of liver transplant candidates by highlighting current indications, technical aspects and barriers with available solutions to facilitate the guidance of available strategies for healthcare professionals in specialized centres.</p><p><strong>Methods: </strong>A review of the most recent relevant literature was conducted for all the cancer indications of liver transplantation including colorectal cancer liver metastases, hilar cholangiocarcinoma, intrahepatic cholangiocarcinoma, neuroendocrine tumours, hepatocellular carcinoma and hepatic epitheloid haemangioendothelioma.</p><p><strong>Results: </strong>Transplant benefit from the best available evidence, including SECA I, SECA II, TRANSMET studies for colorectal liver metastases, various preoperative protocols for cholangiocarcinoma patients, standard, extended selection criteria for hepatocellular carcinoma and neuroendocrine tumours, are discussed. Innovative approaches to deal with organ shortages, including machine-perfused deceased grafts, living donor liver transplantation and RAPID procedures, are also explored.</p><p><strong>Conclusion: </strong>Cancer indications for liver transplantation are here to stay, and the selection criteria among all cancer groups are likely to evolve further with improved prognostication of tumour biology using adjuncts such as radiomics, cancer genomics, and circulating DNA and RNA status. International prospective registry-based studies could overcome the limitations of smaller patient cohorts and lack of level 1 evidence.</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"9 3","pages":""},"PeriodicalIF":3.5,"publicationDate":"2025-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12084677/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144085908","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of transverse versus midline periumbilical incision on incisional hernia and short-term outcomes after laparoscopic colon cancer surgery: multicentre, open-label, randomized clinical trial. 脐周横切线与中线切口对腹腔镜结肠癌手术后切口疝和短期预后的影响:多中心、开放标签、随机临床试验
IF 3.5 3区 医学 Q1 SURGERY Pub Date : 2025-05-07 DOI: 10.1093/bjsopen/zraf062
Soo Young Lee, Soo Yeun Park, Gi Won Ha, Gyung Mo Son, Dong Keon Yon, Chang Hyun Kim

Background: This study aimed to assess the effect of a periumbilical transverse incision compared with a periumbilical midline incision in reducing incisional hernia and improving short-term outcomes after laparoscopic colon cancer surgery.

Methods: This multicentre, open-label, randomized clinical trial was conducted at four high-volume hospitals in Korea, between April 2021 and February 2023. Patients were eligible if they were aged ≥ 20 years and had pathologically confirmed colon cancer. Block randomization was undertaken in a 1 : 1 ratio to transverse versus midline groups, stratified by tumour location. The primary endpoint was the incidence of radiological incisional hernia at 12 months after surgery. The secondary endpoints included symptomatic incisional hernia and short-term outcomes such as outcomes during surgery, complications at 30 days after surgery, pain after surgery, hospital stay after surgery, and patient-reported questionnaires.

Results: Of 174 enrolled patients, 155 were analysed for primary outcome (79 in transverse group and 76 in midline group). Radiological incisional hernia was significantly less frequent in the transverse group (6%) compared with the midline group (18%) 12 months after surgery (P = 0.022); however, there was no significant difference in the incidence of symptomatic incisional hernia between the two groups (3 versus 8%; P = 0.162). Surgical outcomes, complications after surgery, pain, and length of hospital stay did not differ significantly between the two groups. The transverse group had a shorter incision length (mean(standard deviation) 5.0(0.8) versus 5.3(0.8) cm; P = 0.027) and higher cosmesis score (18.0(3.2) versus 16.6(2.7); P = 0.006) than the midline group.

Conclusion: A periumbilical transverse incision significantly reduced radiological incisional hernia compared with a midline incision in laparoscopic colon cancer surgery. Clinical Research Information Service registration number: KCT0006082 (https://cris.nih.go.kr).

背景:本研究旨在评估脐周横向切口与脐周中线切口在腹腔镜结肠癌手术后减少切口疝和改善短期预后方面的效果。方法:这项多中心、开放标签、随机临床试验于2021年4月至2023年2月在韩国四家大医院进行。年龄≥20岁且病理证实为结肠癌的患者入选。横线组和中线组按1:1的比例进行分组随机化,按肿瘤位置分层。主要终点是术后12个月放射切口疝的发生率。次要终点包括有症状的切口疝和短期结果,如手术期间的结果、手术后30天的并发症、手术后疼痛、手术后住院时间和患者报告的问卷。结果:174例入组患者中,155例进行了主要结局分析(横行组79例,中行组76例)。术后12个月,横切线组放射切口疝发生率(6%)明显低于中线组(18%)(P = 0.022);然而,两组在有症状的切口疝发生率上无显著差异(3% vs 8%;P = 0.162)。手术结果、术后并发症、疼痛和住院时间在两组之间没有显著差异。横切组切口长度较短(平均(标准差)5.0(0.8)比5.3(0.8)cm;P = 0.027)和更高的美容评分(18.0(3.2)比16.6(2.7);P = 0.006)高于中线组。结论:在腹腔镜结肠癌手术中,脐周横切口较中线切口能显著减少放射学切口疝。临床研究信息服务注册号:KCT0006082 (https://cris.nih.go.kr)。
{"title":"Effect of transverse versus midline periumbilical incision on incisional hernia and short-term outcomes after laparoscopic colon cancer surgery: multicentre, open-label, randomized clinical trial.","authors":"Soo Young Lee, Soo Yeun Park, Gi Won Ha, Gyung Mo Son, Dong Keon Yon, Chang Hyun Kim","doi":"10.1093/bjsopen/zraf062","DOIUrl":"10.1093/bjsopen/zraf062","url":null,"abstract":"<p><strong>Background: </strong>This study aimed to assess the effect of a periumbilical transverse incision compared with a periumbilical midline incision in reducing incisional hernia and improving short-term outcomes after laparoscopic colon cancer surgery.</p><p><strong>Methods: </strong>This multicentre, open-label, randomized clinical trial was conducted at four high-volume hospitals in Korea, between April 2021 and February 2023. Patients were eligible if they were aged ≥ 20 years and had pathologically confirmed colon cancer. Block randomization was undertaken in a 1 : 1 ratio to transverse versus midline groups, stratified by tumour location. The primary endpoint was the incidence of radiological incisional hernia at 12 months after surgery. The secondary endpoints included symptomatic incisional hernia and short-term outcomes such as outcomes during surgery, complications at 30 days after surgery, pain after surgery, hospital stay after surgery, and patient-reported questionnaires.</p><p><strong>Results: </strong>Of 174 enrolled patients, 155 were analysed for primary outcome (79 in transverse group and 76 in midline group). Radiological incisional hernia was significantly less frequent in the transverse group (6%) compared with the midline group (18%) 12 months after surgery (P = 0.022); however, there was no significant difference in the incidence of symptomatic incisional hernia between the two groups (3 versus 8%; P = 0.162). Surgical outcomes, complications after surgery, pain, and length of hospital stay did not differ significantly between the two groups. The transverse group had a shorter incision length (mean(standard deviation) 5.0(0.8) versus 5.3(0.8) cm; P = 0.027) and higher cosmesis score (18.0(3.2) versus 16.6(2.7); P = 0.006) than the midline group.</p><p><strong>Conclusion: </strong>A periumbilical transverse incision significantly reduced radiological incisional hernia compared with a midline incision in laparoscopic colon cancer surgery. Clinical Research Information Service registration number: KCT0006082 (https://cris.nih.go.kr).</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"9 3","pages":""},"PeriodicalIF":3.5,"publicationDate":"2025-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12131159/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144207593","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Assessment of nodal staging and risk factors for nodal involvement in gallbladder cancer. 胆囊癌淋巴结累及的分期及危险因素评估。
IF 3.5 3区 医学 Q1 SURGERY Pub Date : 2025-05-07 DOI: 10.1093/bjsopen/zraf056
Anita Balakrishnan, Petros Barmpounakis, Nikolaos Demiris, Bodil Andersson, Alejandro Brañes, Xavier de Aretxabala, Malin Sternby Eilard, Paul Gibbs, Simon J F Harper, Emmanuel L Huguet, Asif Jah, Vasilis Kosmoliaptsis, Javier Lendoire, Siong S Liau, Shishir Maithel, Jack L Martin, Colin Noel, Raaj K Praseedom, Alejandro Serrablo, Volkan Adsay

Background: Nodal assessment in gallbladder cancer remains challenging, particularly in incidental gallbladder cancer. This understages the number of patients with node-positive disease, resulting in prognostic inaccuracy and insufficient adjuvant treatment. This study aimed to identify risk factors for positive nodes in gallbladder cancer and to compare prognostic discrimination of available nodal staging parameters.

Methods: This international cohort study assessed gallbladder cancer resections undertaken between 1 January 2010 and 31 December 2020. Logistic regression was used to identify risk factors for node-positive status and develop a risk prediction score for positive nodes. Nodal staging models, including nodal site, number of positive nodes, and positive node ratio were compared for greatest prognostic discrimination in gallbladder cancer.

Results: A total of 3676 patients underwent gallbladder cancer resection across 133 centres in 41 countries. Tumour (T) stage (T2, P = 0.012; T3, P = 0.002; and T4, P < 0.001), lymphovascular and perineural infiltration (P < 0.001), and tumour differentiation (P < 0.001) carried the greatest risk of positive nodes. These three parameters comprised the OMEGA Node Positivity Prediction Score (OMEGA-NOPPS) with C-statistics of 0.81 (95% confidence interval 0.78 to 0.84) in the training data set and 0.79 (0.73 to 0.85) in the test data set for identification of node-positive status, highlighting a ≥ 20% increased risk of positive nodes in poorly differentiated tumours with lymphovascular and perineural infiltration despite T1 disease.

Conclusion: Data from this large multicentre study confirmed that the number of positive nodes is the most discriminative prognostic model for nodal staging in gallbladder cancer. OMEGA-NOPPS provides three simple parameters to stratify nodal involvement according to risk. Incidental gallbladder cancer with lymphovascular and perineural infiltration and poorly differentiated tumours, including early T stages, should be considered for further treatment.

背景:胆囊癌的淋巴结评估仍然具有挑战性,特别是在偶发胆囊癌中。这低估了淋巴结阳性疾病患者的数量,导致预后不准确和辅助治疗不足。本研究旨在确定胆囊癌阳性淋巴结的危险因素,并比较可用淋巴结分期参数的预后判别。方法:这项国际队列研究评估了2010年1月1日至2020年12月31日期间进行的胆囊癌切除术。采用Logistic回归识别节点阳性状态的危险因素,并为阳性节点制定风险预测评分。比较胆囊癌的淋巴结分期模型,包括淋巴结位置、阳性淋巴结数量和阳性淋巴结比例,以判断胆囊癌预后。结果:41个国家133个中心共3676名患者接受了胆囊癌切除术。肿瘤(T)分期(T2, P = 0.012;T3, p = 0.002;和T4, P < 0.001)、淋巴血管和神经周围浸润(P < 0.001)和肿瘤分化(P < 0.001)的阳性淋巴结风险最大。这三个参数组成OMEGA淋巴结阳性预测评分(OMEGA- nopps),在训练数据集中的c统计量为0.81(95%置信区间0.78 - 0.84),在测试数据集中的c统计量为0.79(0.73 - 0.85),用于识别淋巴结阳性状态,强调在T1疾病的低分化肿瘤伴淋巴血管和神经周围浸润的阳性淋巴结风险增加≥20%。结论:这项大型多中心研究的数据证实,阳性淋巴结的数量是胆囊癌淋巴结分期最具鉴别性的预后模型。OMEGA-NOPPS提供三个简单的参数,根据风险对淋巴结累及进行分层。偶发性胆囊癌伴淋巴血管和神经周围浸润和低分化肿瘤,包括早期T期,应考虑进一步治疗。
{"title":"Assessment of nodal staging and risk factors for nodal involvement in gallbladder cancer.","authors":"Anita Balakrishnan, Petros Barmpounakis, Nikolaos Demiris, Bodil Andersson, Alejandro Brañes, Xavier de Aretxabala, Malin Sternby Eilard, Paul Gibbs, Simon J F Harper, Emmanuel L Huguet, Asif Jah, Vasilis Kosmoliaptsis, Javier Lendoire, Siong S Liau, Shishir Maithel, Jack L Martin, Colin Noel, Raaj K Praseedom, Alejandro Serrablo, Volkan Adsay","doi":"10.1093/bjsopen/zraf056","DOIUrl":"10.1093/bjsopen/zraf056","url":null,"abstract":"<p><strong>Background: </strong>Nodal assessment in gallbladder cancer remains challenging, particularly in incidental gallbladder cancer. This understages the number of patients with node-positive disease, resulting in prognostic inaccuracy and insufficient adjuvant treatment. This study aimed to identify risk factors for positive nodes in gallbladder cancer and to compare prognostic discrimination of available nodal staging parameters.</p><p><strong>Methods: </strong>This international cohort study assessed gallbladder cancer resections undertaken between 1 January 2010 and 31 December 2020. Logistic regression was used to identify risk factors for node-positive status and develop a risk prediction score for positive nodes. Nodal staging models, including nodal site, number of positive nodes, and positive node ratio were compared for greatest prognostic discrimination in gallbladder cancer.</p><p><strong>Results: </strong>A total of 3676 patients underwent gallbladder cancer resection across 133 centres in 41 countries. Tumour (T) stage (T2, P = 0.012; T3, P = 0.002; and T4, P < 0.001), lymphovascular and perineural infiltration (P < 0.001), and tumour differentiation (P < 0.001) carried the greatest risk of positive nodes. These three parameters comprised the OMEGA Node Positivity Prediction Score (OMEGA-NOPPS) with C-statistics of 0.81 (95% confidence interval 0.78 to 0.84) in the training data set and 0.79 (0.73 to 0.85) in the test data set for identification of node-positive status, highlighting a ≥ 20% increased risk of positive nodes in poorly differentiated tumours with lymphovascular and perineural infiltration despite T1 disease.</p><p><strong>Conclusion: </strong>Data from this large multicentre study confirmed that the number of positive nodes is the most discriminative prognostic model for nodal staging in gallbladder cancer. OMEGA-NOPPS provides three simple parameters to stratify nodal involvement according to risk. Incidental gallbladder cancer with lymphovascular and perineural infiltration and poorly differentiated tumours, including early T stages, should be considered for further treatment.</p>","PeriodicalId":9028,"journal":{"name":"BJS Open","volume":"9 3","pages":""},"PeriodicalIF":3.5,"publicationDate":"2025-05-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12100740/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144207592","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
BJS Open
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1